BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22321055)

  • 1. Can transplantation be zero risk?
    Pondrom S
    Am J Transplant; 2012 Mar; 12(3):509-10. PubMed ID: 22321055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue donation and virus safety: more nucleic acid amplification testing is needed.
    Pruss A; Caspari G; Krüger DH; Blümel J; Nübling CM; Gürtler L; Gerlich WH
    Transpl Infect Dis; 2010 Oct; 12(5):375-86. PubMed ID: 20412535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia.
    Yao F; Seed C; Farrugia A; Morgan D; Cordner S; Wood D; Zheng MH
    Am J Transplant; 2007 Dec; 7(12):2723-6. PubMed ID: 17983391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral transmission by blood, organs and tissues.
    Yap PL
    J Hosp Infect; 1999 Dec; 43 Suppl():S137-44. PubMed ID: 10658769
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible virus contaminants in tissue banking.
    Starke G
    Beitr Orthop Traumatol; 1990 Sep; 37(9):492-5. PubMed ID: 2248604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keeping human tissue transplants safe.
    Bren L
    FDA Consum; 2005; 39(3):30-6. PubMed ID: 16127818
    [No Abstract]   [Full Text] [Related]  

  • 7. Organ donor viral screening and its implications in transplantation; an overview.
    Sarmento A; Freitas F; Tavares AP; Machado D
    Transplant Proc; 2000 Dec; 32(8):2571-6. PubMed ID: 11134713
    [No Abstract]   [Full Text] [Related]  

  • 8. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
    Seem DL; Lee I; Umscheid CA; Kuehnert MJ
    Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of viruses found with plasma proteins.
    Horowitz B
    Biotechnology; 1991; 19():417-30. PubMed ID: 1786476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ utilization from increased infectious risk donors: An observational study.
    L'Huillier AG; Humar A; Payne C; Kumar D
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28981193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical concerns with organ donation.
    Chase P
    S C Nurse (1994); 2002; 9(4):23. PubMed ID: 12448916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Careful optimism when it comes to xenotransplantations].
    Larsson E; Tibell A
    Lakartidningen; 1998 Mar; 95(12):1283-6. PubMed ID: 9542842
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging viral infections relevant to transfusion medicine.
    Allain JP
    Blood Rev; 2000 Dec; 14(4):173-81. PubMed ID: 11124105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a transplantation transmission sentinel network to improve safety and traceability of organ and tissues.
    Strong DM; Seem D; Taylor G; Parker J; Stewart D; Kuehnert MJ
    Cell Tissue Bank; 2010 Nov; 11(4):335-43. PubMed ID: 20652419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus transmission from an antibody-negative organ and tissue donor--United States, 2000-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Apr; 52(13):273-4, 276. PubMed ID: 12729075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022.
    Free RJ; Levi ME; Bowman JS; Bixler D; Brooks JT; Buchacz K; Moorman A; Berger J; Basavaraju SV
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):844-846. PubMed ID: 35771714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The last data concerning fungal, bacterial and viral infections after cell, tissue and organ transplantations and other problems concerning mycology and parasitology presented at 49th Clinical Day of Medical Parasitology].
    Wójcik A; Błaszkowska J
    Wiad Parazytol; 2010; 56(3):281-9. PubMed ID: 21179672
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of transmission of HIV by organ and tissue transplantation. HIV testing protocol and a proposal for recommendations concerning donor selection.
    Patijn GA; Strengers PF; Harvey M; Persijn G
    Transpl Int; 1993 May; 6(3):165-72. PubMed ID: 8499070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot projects lay foundation for national tissue surveillance and traceability system.
    Moulton D; Kondro W
    CMAJ; 2010 Apr; 182(6):E259-60. PubMed ID: 20212034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.